Healthleap, a startup founded by siblings Jemima and Josiah Meyer, has raised $38 million to expand its AI platform that identifies undiagnosed patient illnesses in hospital records.
When a patient enters a hospital, their chart often contains a fragmented story. While doctors meticulously record lab results and vitals in structured fields. the most vital clues—a patient’s reported weight loss. muscle atrophy. or difficulty swallowing—frequently remain buried in the margins of unstructured clinical notes. It is in this gap that Healthleap is betting its future.
After raising $38 million in combined seed and Series A funding. the startup is accelerating its mission to surface these hidden signals. The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital. followed by a $30 million Series A led by Hummingbird Ventures. While the founders are not disclosing the company’s valuation. the capital injection marks a significant milestone for the South African-born venture.
Founded in 2022 by siblings Jemima and Josiah Meyer, the company originally focused on a clinical nutrition tool. That early iteration has since evolved into a general-purpose platform now deployed in more than 50 hospitals. The system acts as a digital night watchman: every evening. it scans thousands of records—lab results. medications. diet orders. and clinician notes—using language models to identify risks like malnutrition. delirium. aspiration pneumonia. and pressure ulcers. By each morning, it places a risk score directly into the care team’s workflow.
This shift from a niche nutrition tool to a diagnostic-support powerhouse is driven by the reality of clinical oversight. Malnutrition alone affects an estimated 20% to 50% of hospital inpatients. often triggering a cascade of complications. including impaired wound healing. prolonged hospital stays. and increased mortality rates. At the Hospital of the University of Pennsylvania. the company reports that its malnutrition program generated a $23.8 million annualized financial impact. split between $6.3 million in additional reimbursement and $17.5 million saved through shorter stays.
“A patient’s chart holds two kinds of data,” Josiah Meyer said. “The most telling signs sit in clinicians’ written notes: poor appetite, recent weight loss, muscle loss, trouble swallowing. Our developing approach is extracting affirmative or negated mentions of these clinical concepts in an easily extensible and scalable way.”.
Healthleap’s growth trajectory has been swift. Over the past year. the company expanded from three hospital partners to more than 50. a roster that now includes major names like Penn Medicine. Cedars-Sinai. Intermountain. Houston Methodist. and Emory Healthcare. Revenue has grown more than 10x during that same period. The startup operates on three-year contracts priced by licensed bed count, supplemented by an outcome-based model. According to Meyer. every customer has recorded at least a 5x hard return on investment. with some reaching upwards of 20x.
The company emphasizes that its software is a tool for clinicians, not a replacement for them. It does not issue diagnoses; it flags items for human review. Looking ahead, the infusion of capital is earmarked for scaling engineering, sales, and product teams. The goal is ambitious: to eventually monitor more than 40 major health conditions and push the platform’s reach beyond the hospital walls into outpatient and home care settings.
Healthleap AI healthcare patient risk digital health hospital tech medical startup Josiah Meyer Jemima Meyer